Impressive Bleeding Profile With Factor XI Inhibitor in AF ...Middle East

Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF. Medscape Medical News

Hence then, the article about impressive bleeding profile with factor xi inhibitor in af was published today ( Tuesday 14/11/2023 - 12:48 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Impressive Bleeding Profile With Factor XI Inhibitor in AF )

Also on site :

• Inside the epicenter of the Ebola outbreak in DRC as the virus spreads
• White House shooter Naseer Best, 21, who identified himself as Jesus Christ shot dead
• The Middle East war is testing the Gulf’s ambitions to become an AI hub